Latest News

Expert Shares Her Phased Approach to Caring for Patients with Delusional Infestation


 

FROM AAD 2024

— In the clinical opinion of Jenny E. Murase, MD, caring for patients with delusional infestation — the conviction that one is infested by animate or inanimate pathogens without medical or microbiological evidence of a true infestation — puts a dermatologist’s communication skills to the ultimate test.

“The fact that delusional infestation is a fixed, false belief [means] we will never agree with patients on the etiology by definition,” Dr. Murase, a dermatologist with the Palo Alto Foundation Medical Group, Mountain View, California, said at the annual meeting of the American Academy of Dermatology. “But somehow, we must come to some kind of an agreement on how to approach this therapeutically.”

Dr. Jenny E. Murase, University of California, San Francisco, department of dermatology

Dr. Jenny E. Murase

Patients with delusional infestation (DI) often describe a cutaneous sensation of itching or crawling, biting, stinging — a pins and needles sensation. “Formication is when there’s a crawling sensation on the surface of the skin,” she said. “That’s something we can agree on — the fact that there is a shared understanding that they’re experiencing some kind of sensation in their skin.”

First described in 1894, several different terms have been used to describe DI in the past, including acarophobia, delusions of parasitosis, Ekbom syndrome, and Morgellons disease. The current term used for DI includes other animate or inanimate pathogens besides parasites.

The average dermatologist manages two to three patients with DI every 5 years, “so it’s not uncommon,” said Dr. Murase, who also holds a faculty position in the department of dermatology at the University of California, San Francisco. Females are about 2.5 times more likely to be affected compared with males, she said, and 8%-12% of patients with DI have a friend or relative who shares the symptom, and they often accompany them to the office visit. “Initially, you’re trying to determine if this a primary condition where it’s only the cutaneous condition the patient is experiencing, or if there is a secondary condition like an underlying psychiatric disorder or medical condition or drug use that contributes to the sensation,” she said.

According to a descriptive study of 115 patients with DI, 50% had at least one drug detected in hair samples, and nearly 60% had evidence of some cognitive impairment that could not be explained by deficits in IQ. Another study of 147 patients with DI seen at the Mayo Clinic between 2001 and 2007 found that 81% had a prior psychiatric condition and 26% had a shared psychotic disorder.

Phased Approach to Treatment

Dr. Murase discussed her phased approach to caring for patients with DI, based on a review article that she and colleagues published in the International Journal of Dermatology. Phase 1 involves preparing for the visit by asking staff to refer to patients with DI as VIPs and allowing them to talk freely about the sensation they’re experiencing. “The goal is to improve the patient’s condition, not to convince the patient that he or she is delusional,” Dr. Murase explained. “Many patients can’t distinguish between when they’re talking to the doctor and when they’re talking to a nurse or a nurse practitioner; they like to feel that they’re being heard and listened to.”

Pages

Recommended Reading

What Skin Manifestations Are Associated With Pediatric IBD?
MDedge Internal Medicine
Study Eyes Longer IV Ertapenem for Recalcitrant Hidradenitis Suppurativa
MDedge Internal Medicine
Patient-Reported Outcomes Predict Mortality in Cutaneous Chronic GVHD
MDedge Internal Medicine
Study Finds No Increased Cancer Risk With Spironolactone
MDedge Internal Medicine
Novel Agent Shows Promise for Hidradenitis Suppurativa
MDedge Internal Medicine
Study Links Maternal Hidradenitis Suppurativa to Risk for Childhood Morbidity
MDedge Internal Medicine
BTK Inhibitor Shows Promise for Hidradenitis Suppurativa
MDedge Internal Medicine
Nemolizumab Efficacy for Prurigo Nodularis Persists at 1 Year
MDedge Internal Medicine
Think Beyond the ‘Go-Tos’ for Wart Management, Expert Advises
MDedge Internal Medicine
Study Highlights Some Semaglutide-Associated Skin Effects
MDedge Internal Medicine